The Dual Nature of Type I and Type II Interferons
- PMID: 30254639
- PMCID: PMC6141705
- DOI: 10.3389/fimmu.2018.02061
The Dual Nature of Type I and Type II Interferons
Abstract
Type I and type II interferons (IFN) are central to both combating virus infection and modulating the antiviral immune response. Indeed, an absence of either the receptor for type I IFNs or IFN-y have resulted in increased susceptibility to virus infection, including increased virus replication and reduced survival. However, an emerging area of research has shown that there is a dual nature to these cytokines. Recent evidence has demonstrated that both type I and type II IFNs have immunoregulatory functions during infection and type II immune responses. In this review, we address the dual nature of type I and type II interferons and present evidence that both antiviral and immunomodulatory functions are critical during virus infection to not only limit virus replication and initiate an appropriate antiviral immune response, but to also negatively regulate this response to minimize tissue damage. Both the activating and negatively regulatory properties of type I and II IFNs work in concert with each other to create a balanced immune response that combats the infection while minimizing collateral damage.
Keywords: immunoregulation; innate immunity; interferon-γ; type I interferon; virus infection.
Figures
Similar articles
-
Functional Interplay between Type I and II Interferons Is Essential to Limit Influenza A Virus-Induced Tissue Inflammation.PLoS Pathog. 2016 Jan 5;12(1):e1005378. doi: 10.1371/journal.ppat.1005378. eCollection 2016 Jan. PLoS Pathog. 2016. PMID: 26731100 Free PMC article.
-
Type I, II, and III Interferons: Regulating Immunity to Mycobacterium tuberculosis Infection.Arch Immunol Ther Exp (Warsz). 2016 Feb;64(1):19-31. doi: 10.1007/s00005-015-0365-7. Epub 2015 Sep 11. Arch Immunol Ther Exp (Warsz). 2016. PMID: 26362801 Review.
-
Contribution of type III interferons to antiviral immunity: location, location, location.J Biol Chem. 2017 May 5;292(18):7295-7303. doi: 10.1074/jbc.R117.777102. Epub 2017 Mar 13. J Biol Chem. 2017. PMID: 28289095 Free PMC article. Review.
-
Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.Immunol Rev. 2008 Dec;226:29-40. doi: 10.1111/j.1600-065X.2008.00698.x. Immunol Rev. 2008. PMID: 19161414 Review.
-
Mechanisms of type III interferon expression.J Interferon Cytokine Res. 2010 Aug;30(8):573-8. doi: 10.1089/jir.2010.0063. J Interferon Cytokine Res. 2010. PMID: 20645874 Review.
Cited by
-
Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes.J Clin Endocrinol Metab. 2023 Mar 10;108(4):931-940. doi: 10.1210/clinem/dgac598. J Clin Endocrinol Metab. 2023. PMID: 36262060 Free PMC article.
-
TNF and IFNγ-induced cell death requires IRF1 and ELAVL1 to promote CASP8 expression.J Cell Biol. 2024 Mar 4;223(3):e202305026. doi: 10.1083/jcb.202305026. Epub 2024 Feb 6. J Cell Biol. 2024. PMID: 38319288 Free PMC article.
-
The modulatory action of C-Vx substance on the immune system in COVID-19.Emerg Microbes Infect. 2022 Dec;11(1):2698-2710. doi: 10.1080/22221751.2022.2125347. Emerg Microbes Infect. 2022. PMID: 36106521 Free PMC article.
-
Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19.Front Immunol. 2021 Feb 18;12:631226. doi: 10.3389/fimmu.2021.631226. eCollection 2021. Front Immunol. 2021. PMID: 33679778 Free PMC article. Clinical Trial.
-
Fetal MAVS and type I IFN signaling pathways control ZIKV infection in the placenta and maternal decidua.J Exp Med. 2024 Sep 2;221(9):e20240694. doi: 10.1084/jem.20240694. Epub 2024 Jul 23. J Exp Med. 2024. PMID: 39042188 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical